News & Analysis as of September 24, 2024

Lobbying › Pro Publica

+ Follow

Raising Money for Federal Candidates
Election Year Compliance Tips for Nonprofit Organizations
Video: Things to Remember in Q1 when Preparing 2024 Federal Lobbying Disclosure Act (LDA) Reports
Early Returns Law & Politics Podcast with Jan Baran - Wes Bizzell: The Role of Corporate America and Associations in Politics
Nonprofit Basics: Election Year Issues for Private Foundations and Public Charities Part 3: Private Foundation Approaches to Policy Advocacy Allowed by the Internal Revenue Code
Nonprofit Basics: Election Year Issues for Private Foundations and Public Charities Part 2: Legislative Lobbying Activities by Public Charities
[Podcast] The LD-203 Contribution Report: Content, Context, and Compliance
A Different Kind of Advocacy | Amy & Steve Bresnen | Texas Appellate Law Podcast
Staying Compliant: Ensure that your Company is Prepared to Comply with the Lobbying Disclosure Act
The Federal Gift Rules Assistant: What You Need to Know and Why
H.R. 1 – The Impact on the FEC
H.R. 1 – How will the Lobbying Disclosure Act be Affected?
H.R. 1 – Disclosures, Disclaimers, and FEC Certifications: What Corporations, Non-Profits, and Trade Associations Need to Know
A Breakdown of the Biden-Harris Transition Ethics Plan
Lifting the Fog Over Lobbying Compliance - updated with impact of COVID-19 on NYS lobbying community
Lifting the Fog Over Lobbying Compliance
Nota Bene Episode 43: Checking In on Congress at the Start of Q3 with Elizabeth Frazee
Konczal: Dodd-Frank Reforms Get Roughed Up in Court
Cybersecurity Lobbying Booming: How Law Firms Can Profit

Big Pharma enlists more useful allies: pay-for-hire academic economists

Patrick Malone & Associates P.C. | DC Injury... on 3/1/2017

It’s a $50-million business with a roster of blue-chip consultants who would be an envied faculty at most any major university. But look closely at the activities of Precision Health Economics because this firm’s esteemed...more

1 Results

View per page

Page: of 1

Lobbying › Pro Publica

Big Pharma enlists more useful allies: pay-for-hire academic economists

"My best business intelligence, in one easy email…"